๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of temozolomide for recurrent embryonal brain tumors in children

โœ Scribed by Chung-Hao Wang; Ting-Rong Hsu; Tai-Tong Wong; Kai-Ping Chang

Publisher
Springer
Year
2008
Tongue
English
Weight
320 KB
Volume
25
Category
Article
ISSN
0256-7040

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of daily oral etoposide i
Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors
โœ Needle, Michael N.; Molloy, Patricia T.; Geyer, J. Russell; Herman-Liu, Alisa; B ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 315 KB ๐Ÿ‘ 2 views

Pre-clinical data and adult experience suggests that topoisomerase targeted anti-cancer agents may be highly schedule dependent, and efficacy may improve with prolonged exposure. To investigate this hypothesis, 28 children with recurrent brain and solid tumors were enrolled in a phase II study of or

Efficacy of postoperative chemotherapy u
Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors
โœ Strauss, Lewis C. ;Killmond, Thomas M. ;Carson, Benjamin S. ;Maria, Bernard L. ; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 671 KB

Neuraxis radiation therapy (RT) for primary intracranial tumors is associated with major late effects if administered to very young children. To control residual tumor and to delay RT, we treated eight young children (median age 6.5 months) with primary central nervous system (CNS) tumors using comb

Phase 2 study of temozolomide in childre
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors : A report from the Children's Oncology Group
โœ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad